Context Therapeutics Inc. - 8-K Filing

Context Therapeutics notified by Nasdaq of failure to meet minimum bid price requirement under Listing Rule 5550(a)(2), with initial compliance period until January 25, 2027 (Items: 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing)

SEC EDGAR ·

Tickers: $CNTX

Read the full article at SEC EDGAR

More Regulatory news